| scholarly article | Q13442814 |
| P2093 | author name string | Ying Yang | |
| Jiahong Xu | |||
| Peng Xi | |||
| Yuan Xie | |||
| Cuimei Zhao | |||
| Jinfa Jiang | |||
| P2860 | cites work | Natural antisense transcript of natriuretic peptide precursor A (NPPA): structural organization and modulation of NPPA expression | Q21263031 |
| Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 | ||
| MicroRNAs are involved in end-organ damage during hypertension | Q26866000 | ||
| Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy | Q28272117 | ||
| Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action | Q28569709 | ||
| Effect of Korea red ginseng on cerebral blood flow and superoxide production. | Q31120314 | ||
| Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice | Q34121996 | ||
| A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. | Q34551734 | ||
| Nitric oxide in hypertension | Q34591297 | ||
| Isolation and analysis of ginseng: advances and challenges | Q34667126 | ||
| Panax ginseng pharmacology: a nitric oxide link? | Q34742901 | ||
| Cancer prevention and therapeutics: Panax ginseng. | Q35896682 | ||
| Plasma membrane transporters for arginine | Q35909702 | ||
| Pharmacological effects of ginseng on liver functions and diseases: a minireview | Q36246669 | ||
| Pharmacological activity of sanchi ginseng (Panax notoginseng). | Q36548823 | ||
| Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension | Q36604954 | ||
| Inflammation, cancer, and targets of ginseng | Q36689621 | ||
| Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension | Q37100212 | ||
| Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer | Q37248856 | ||
| MicroRNA: a new frontier in kidney and blood pressure research | Q37337320 | ||
| Long noncoding RNAs in cardiac development and pathophysiology | Q38056111 | ||
| Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal | Q41913070 | ||
| Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells | Q42283319 | ||
| Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth | Q42455305 | ||
| Hypertension in mice lacking the gene for endothelial nitric oxide synthase | Q42478091 | ||
| Role of nitric oxide in the regulation of vascular tone in pressurized and perfused resistance myometrial arteries from term pregnant women. | Q42546141 | ||
| Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension | Q43789338 | ||
| Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase | Q44477052 | ||
| Chemical assessment of roots of Panax notoginseng in China: regional and seasonal variations in its active constituents. | Q44713761 | ||
| ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. | Q44836516 | ||
| Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease | Q46632496 | ||
| Antithrombotic and antiplatelet activities of Korean red ginseng extract. | Q50704668 | ||
| Effect of Panax notoginseng saponins on increased proliferation of cultured aortic smooth muscle cells stimulated by hypercholesterolemic serum. | Q50781781 | ||
| Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats. | Q53676429 | ||
| Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. | Q54252017 | ||
| Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and beta-catenin/T-cell factor-dependent pathway in human endothelial cells. | Q54536901 | ||
| Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension | Q72166815 | ||
| Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway | Q72611416 | ||
| Bioactive saponins and glycosides. VIII. Notoginseng (1): new dammarane-type triterpene oligoglycosides, notoginsenosides-A, -B, -C, and -D, from the dried root of Panax notoginseng (Burk.) F.H. Chen | Q73492484 | ||
| Effects of red ginseng upon vascular endothelial function in patients with essential hypertension | Q74351234 | ||
| Characterization of L-arginine uptake by plasma membrane vesicles isolated from cultured pulmonary artery endothelial cells | Q74404132 | ||
| Effect of red ginseng on blood pressure in patients with essential hypertension and white coat hypertension | Q77503822 | ||
| Haemolytic activities and immunologic adjuvant effect of Panax notoginseng saponins | Q79307784 | ||
| Cyclic guanosine monophosphate phosphodiesterase-5 inhibitor promotes an endothelium NO-dependent-like vasodilation in patients with refractory hypertension | Q79716568 | ||
| Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells | Q83333509 | ||
| Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells | Q83516147 | ||
| P433 | issue | 3 | |
| P921 | main subject | non-coding RNA | Q427087 |
| P304 | page(s) | 2700-2709 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | International Journal of Clinical and Experimental Pathology | Q6051341 |
| P1476 | title | Notoginsenoside R1 reduces blood pressure in spontaneously hypertensive rats through a long non-coding RNA AK094457. | |
| P478 | volume | 8 |
| Q90352972 | Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease |
| Q89906820 | Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases |
| Q89574435 | Knockdown of Long Noncoding RNA (lncRNA) AK094457 Relieved Angiotensin II Induced Vascular Endothelial Cell Injury |
| Q39013743 | Long Non-Coding RNAs: A Novel Paradigm for Toxicology |
| Q89532845 | Long noncoding RNAs as novel players in the pathogenesis of hypertension |
| Q52650049 | Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis. |
| Q64944513 | Notoginsenoside R1 protects human keratinocytes HaCaT from LPS-induced inflammatory injury by downregulation of Myd88. |
| Q36257682 | Probiotics Blunt the Anti-Hypertensive Effect of Blueberry Feeding in Hypertensive Rats without Altering Hippuric Acid Production |
Search more.